financetom
Business
financetom
/
Business
/
Latham Group Reports Q4 Loss, Lower Sales; 2025 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Latham Group Reports Q4 Loss, Lower Sales; 2025 Outlook Set
Mar 4, 2025 3:02 PM

05:37 PM EST, 03/04/2025 (MT Newswires) -- Latham Group ( SWIM ) posted a Q4 loss late Tuesday of $0.25 per diluted share, compared with a breakeven result a year earlier.

Four analysts surveyed by FactSet expected a loss of $0.11 per share.

Net sales for the quarter ended Dec. 31 were $87.3 million, down from $90.9 million a year earlier.

Analysts surveyed by FactSet expected $85.1 million.

For 2025, the company said it expects net sales of $535 million to $565 million. Analysts surveyed by FactSet expect $528.4 million.

Shares of the company jumped past 18% in recent after-hours activity.

Price: 6.46, Change: +1.00, Percent Change: +18.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Denali Therapeutics Q3 net loss widens to $126.9 mln
Denali Therapeutics Q3 net loss widens to $126.9 mln
Nov 6, 2025
Overview * Denali Q3 net loss widens to $126.9 mln from $107.2 mln last year * Operating expenses increased due to R&D and commercial launch preparations * FDA extends tividenofusp alfa review timeline to April 2026 from January Outlook * Denali expects to launch tividenofusp alfa for Hunter syndrome after FDA review by April 2026 * Company plans global Phase...
Topgolf Callaway Q3 revenue beats expectations on robust gold equipment demand 
Topgolf Callaway Q3 revenue beats expectations on robust gold equipment demand 
Nov 6, 2025
Overview * Topgolf Callaway Q3 revenue grows 3% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats consensus, driven by Golf Equipment and Topgolf segments * Company raises full year 2025 revenue and adjusted EBITDA guidance Outlook * Company raises full-year 2025 revenue guidance to $3.90 bln-$3.94 bln * Topgolf revenue guidance increased to $1.77 bln-$1.79 bln * Full-year...
Structure Therapeutics Q3 loss widens to $65.7 mln
Structure Therapeutics Q3 loss widens to $65.7 mln
Nov 6, 2025
Overview * Structure Therapeutics ( GPCR ) reports Q3 net loss of $65.7 mln, compared to $34 mln in 2024 * Company maintains strong cash position of $799 mln, funding operations through 2027 * Phase 1 study for oral amylin receptor agonist ACCG-2671 to start by year-end 2025 Outlook * Structure Therapeutics ( GPCR ) expects topline data from ACCESS...
BioLife Q3 revenue up 31%, raises 2025 guidance
BioLife Q3 revenue up 31%, raises 2025 guidance
Nov 6, 2025
Overview * BioLife Q3 2025 total revenue rises 31% yr/yr, driven by cell processing growth * Cell processing revenue increases 33% yr/yr * Company raises full-year 2025 revenue guidance to $95.0 mln - $96.0 mln Outlook * BioLife raises 2025 Cell Processing revenue guidance to $93 mln - $94 mln * Company updates 2025 total revenue guidance to $95 mln...
Copyright 2023-2026 - www.financetom.com All Rights Reserved